Gyrodyne, LLC

Gyrodyne, LLC

GYRO
Gyrodyne, LLCUS flagNASDAQ Capital Market
5.70
USD
-0.15
- -
12.54MMarket Cap
Gyrodyne, LLC
GYRO
(NASDAQ Capital Market)

Recent

price

5.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2006
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2021
2022
2023
2024
2025
TTM
FRC
14.63
- -
25.22
29.03
41.45
47.6
45.54
37.22
37.53
36.92
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
117.99
- -
-13.41
13.22
13.06
-9.27
-9.28
738.98
343.67
1.1
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
215.5
- -
-61.36
-77.95
-143.79
-17.79
-10.38
1,202.26
-67.11
-48.76
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
44.6
- -
- -
- -
- -
423.67
507.3
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
122.16
- -
55.61
68.4
81.46
72.19
61.77
371.16
-55.18
-59.16
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
181.16
- -
112.57
108.78
125.48
128.29
197.92
483.22
208.88
175.01
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
2
- -
3
3
5
6
6
5
5
5
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-90
- -
-61.45
-30.83
-39.89
4.81
7.33
-116.13
-270.96
-60.95
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
1
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
13
- -
-2
2
2
-1
-1
99
46
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
38.91
- -
- -
- -
- -
- -
- -
38.36
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
806.28
- -
-53.17
45.55
31.5
-19.48
-20.38
1,985.29
915.78
2.98
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
18
25
14
4
-1
2
11
98
13
9
10
-9
-14
- -
- -
- -
- -
Working Capital
- -
- -
6
11
18
22
21
5
16
18
- -
10
10
- -
- -
- -
- -
LT Debt
20
20
13
13
15
15
24
65
28
23
- -
- -
- -
- -
- -
- -
- -
Total Equity
-4.78
- -
- -
- -
- -
- -
- -
-6.22
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
186.55
- -
- -
- -
- -
- -
- -
238.98
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
186.8
- -
-15.85
21.4
17.43
-12.07
-14.14
346.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
11
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5
- -
- -
Cash, Cash Equivalents & STI
5
5
4
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
17
- -
- -
Payables & Accruals
3
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Gyrodyne, LLC Gyrodyne, LLC owns and manages a diversified portfolio of industrial, office, medical office, and service-oriented real estate properties located in the New York metropolitan area, primarily in Suffolk and Westchester Counties. The company offers leasing services for its properties, including light industrial buildings and office spaces at the 63-acre Flowerfield site in St. James on Long Island's north shore, approximately 50 miles east of New York City; a 13.8-acre medical office park featuring the 31,421-square-foot Cortlandt Medical Center in Cortlandt Manor; and undeveloped land parcels suitable for value-enhancing entitlements and redevelopment into medical office, residential, and mixed-use facilities. Gyrodyne focuses on strategic asset management, subdivision applications, and entitlement pursuits to maximize property values, with operations centered on tenant leasing at 82% occupancy across 32 tenants as of late 2024, targeting medical, industrial, and professional service tenants in proximity to key institutions like Stony Brook University Hospital and New York-Presbyterian Hudson Valley Hospital. Founded in 1946 and headquartered at One Flowerfield, Suite 24, St. James, New York, the company transitioned from helicopter manufacturing to real estate in 1975 and trades on the Nasdaq Capital Market under the symbol GYRO. In recent developments, Gyrodyne announced on August 4, 2025, an agreement through its subsidiary GSD Flowerfield, LLC to sell approximately 49 acres of vacant land at the Flowerfield complex in Smithtown, New York, to B2K Smithtown LLC for between $24 million and $28.74 million; entered into a shareholder agreement with Star Equity Fund, LP on October 17, 2025, reducing its board size from five to four directors while implementing director compensation limits to support property sales and value maximization; and advances rezoning for a Medical Oriented District at Cortlandt Manor, proposing at least 80,000 square feet of Class A medical office space and over 160 residential units alongside community greenways and partnerships with local stakeholders including the Town of Cortlandt and New York-Presbyterian Hospital.

Company News

APIChatGPT
  • Comparing Cushman & Wakefield (NYSE:CWK) & Gyrodyne (NASDAQ:GYRO)

  • Comparing Gyrodyne (NASDAQ:GYRO) and Cushman & Wakefield (NYSE:CWK)

  • Gyrodyne (NASDAQ:GYRO) Stock Price Passes Below 200 Day Moving Average – Here’s What Happened

  • Gyrodyne Announces Agreement with Star Equity Fund

  • GYRODYNE, LLC ANNOUNCES AGREEMENT TO SELL 49-ACRE PARCEL IN SMITHTOWN, NEW YORK AS PART OF STRATEGIC LIQUIDATION PLAN

  • New York Supreme Court Rules in Favor of Gyrodyne in Article 78 Proceeding

  • GYRODYNE ANNOUNCES CLOSING OF SUCCESSFUL, OVERSUBSCRIBED RIGHTS OFFERING

  • GYRODYNE ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING

  • GYRODYNE ANNOUNCES RECORD DATE FOR PROPOSED RIGHTS OFFERING

  • Gyrodyne Announces Agreement with Star Equity Fund

  • Gyrodyne Appoints Jan Loeb to Board of Directors

  • 6 Stocks Halted In Thursday's Session

  • St. James’s Hospital Dublin's history as a workhouse for destitute beggars | IrishCentral.com

  • London Marathon becomes elite-only race running laps in St James' Park

  • A Gentleman’s Guide To London According To Tom Chamberlin

  • £9.25m Paper Tycoon's Mansion For Sale in Westminster

  • Police dragnet catches Westmoreland’s most wanted

  • Maggie's Centre, St James's hospital, Leeds review – a safe place for flamboyance

  • Sparta Gang bust - St James most wanted nabbed in St Andrew police raid

  • Newcastle fan's view: yes, we wanted the riches but mostly we wanted rid of Ashley | Harry Savill